Personalized prediction for a 67 year old man who takes Amlodipine, Euthyrox (an AI-powered real world drug study)

Summary:

This is a personalized prediction of potential side effects and undetected conditions for up to one year, if you would have adverse effects. The study is created by eHealthMe based on data from the FDA.


On Sep, 21, 2025, 2,684,259 related reports were analyzed:

What are the drugs?

  • Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,717 Amlodipine users. Check the latest studies of Amlodipine.
  • Euthyrox has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 8,739 Euthyrox users. Check the latest studies of Euthyrox.

What are the conditions?


Potential side effects:

Appetite - decreased
  • 5.36% for males aged 67 (±5) who have hashimoto's thyroiditis
Depression
  • 8.04% for males aged 67 (±5) who have hashimoto's thyroiditis
Diarrhea
  • 8.93% for males aged 67 (±5) who have hashimoto's thyroiditis
Disease recurrence
  • 5.36% for males aged 67 (±5) who have hashimoto's thyroiditis
Dizziness
  • 6.25% for males aged 67 (±5) who have hashimoto's thyroiditis
Drug ineffective
  • 8.04% for males aged 67 (±5) who have hashimoto's thyroiditis
Fatigue
  • 7.14% for males aged 67 (±5) who have hashimoto's thyroiditis
Headache
  • 5.36% for males aged 67 (±5) who have hashimoto's thyroiditis
High blood pressure
  • 5.77% for males aged 67 (±5) who have hashimoto's thyroiditis and hypertension
Nasopharyngitis
  • 5.36% for males aged 67 (±5) who have hashimoto's thyroiditis
Weakness
  • 5.36% for males aged 67 (±5) who have hashimoto's thyroiditis
Weight decreased
  • 7.14% for males aged 67 (±5) who have hashimoto's thyroiditis

Potential co-existing conditions:

Asthma
  • 7.14% for males aged 67 (±5) who have hashimoto's thyroiditis
Atrial fibrillation/flutter
  • 6.73% for males aged 67 (±5) who have hashimoto's thyroiditis and hypertension
Chronic fatigue syndrome
  • 6.25% for males aged 67 (±5) who have hashimoto's thyroiditis
Constipation
  • 7.14% for males aged 67 (±5) who have hashimoto's thyroiditis
Crohn's disease
  • 7.14% for males aged 67 (±5) who have hashimoto's thyroiditis
Depression
  • 14.29% for males aged 67 (±5) who have hashimoto's thyroiditis
Diabetes
  • 14.18% for males aged 67 (±5) who have hashimoto's thyroiditis and hypertension
Dyslipidaemia
  • 5.36% for males aged 67 (±5) who have hashimoto's thyroiditis
Eyelid disorder
  • 5.36% for males aged 67 (±5) who have hashimoto's thyroiditis
Fibromyalgia
  • 6.25% for males aged 67 (±5) who have hashimoto's thyroiditis
Gastroesophageal reflux disease
  • 7.87% for males aged 67 (±5) who have hashimoto's thyroiditis and hypertension
High blood cholesterol
  • 16.54% for males aged 67 (±5) who have hashimoto's thyroiditis and hypertension
Hyperlipidaemia
  • 5.5% for males aged 67 (±5) who have hashimoto's thyroiditis and hypertension
Hypoparathyroidism
  • 5.36% for males aged 67 (±5) who have hashimoto's thyroiditis
Memory loss
  • 5.36% for males aged 67 (±5) who have hashimoto's thyroiditis
Multiple myeloma
  • 5.01% for males aged 67 (±5) who take amlodipine
  • 5.01% for males aged 67 (±5) who take euthyrox
Muscle spasms
  • 5.36% for males aged 67 (±5) who have hashimoto's thyroiditis
Osteoporosis
  • 7.14% for males aged 67 (±5) who have hashimoto's thyroiditis
Pain
  • 8.28% for males aged 67 (±5) who have hashimoto's thyroiditis and hypertension
Pneumonia
  • 5.36% for males aged 67 (±5) who have hashimoto's thyroiditis
Stress and anxiety
  • 8.93% for males aged 67 (±5) who have hashimoto's thyroiditis
Type 2 diabetes
  • 8.9% for males aged 67 (±5) who have hashimoto's thyroiditis and hypertension

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used, and more. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe:

Recent personalized studies on eHealthMe: